FDA Investigator Gabriel R Mclemore
Gabriel R Mclemore has conducted inspections on 47 sites in 1 countries as of 14 Sep 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
47
Last Inspection Date:
14 Sep 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gabriel R Mclemore:
Aaron P Wozniak,
Abdur Rashid,
Adam J Williams,
Adam R Cooke,
Alphonso A Haupt, III,
Amanda L Evanco,
Amy H Ruble,
Anthony S Puckett,
Arlyss M Jones,
Arthur G Hurst,
Babatunde D Babalola,
Barbara M Frazier,
Beth F Fritsch,
Betsy C Galliher,
Billy M Battles,
Bonita S Chester,
Brandy D Brown,
Burnell M Henry,
Calvin Foulks,
Carlos A Ortiz,
Carlos M Gonzalez,
Carol F Robinson,
Carol J Blackwood,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Christian D Lynch (CDL),
Christie B Rice,
Christina H Owens,
Christine M O'leary,
Christopher J Adams,
Christopher S Keating,
Claire M Minden,
Claudette D Brooks,
Constance Y Fears,
Cordelia J Brammer,
Cynthia Jim, CSO,
D Ross Spears, PhD,
Daphne Santiago, PhD,
David T Glover,
Demario L Walls,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Edward Deberry,
Eileen J Bannerman,
Eric S Weilage,
Erin C Hill,
Erin Hill (EH),
Ernest H Blackwood,
Fabian Nchaparro Rodriguez,
Frank Wackes,
Gabriel M Guevarra,
Gabriel Mclemore,
Geraldine D Sanders,
Gideon N Esuzor,
Hai Lient Phung,
Hector A Carrero,
Ibad U Khan,
Igbinoba,
Ivy E Sweeney,
Jacqueline D Mitchell,
Jacqueline Mdiaz Albertini,
Jamirya S Weatherly,
Jared P Stevens,
Jason F Chancey,
Jason R Nickelsen,
Jawaid Hamid,
Jeffrey D Sheppard,
Jennifer D Hollstrom,
Joanne T Gabay,
Johnetta F Walters,
Jonathan G Swoboda,
Joseph F Owens,
Karen L Anderson,
Katelynn J Gulya,
Katelynn J Rollins,
Kathleen D Culver,
Keri U Walker,
Kimberly Cdelk Brooks,
Kip J Hanks,
Lareese K Thomas,
Larry K Hampton,
Laura D Cain,
Laura L Staples,
Laurel A Beer,
Lawrence Carter, III,
Lawrence Thomas,
Leah M Andrews,
Leroy M Anderson,
Lesley K Satterwhite,
Leslie W Gilbert,
Libia M Lugo,
Lorenzo Jones,
LT Daveta L Bailey,
LT Tamara J Henderson,
Luis Mburgos Medero,
Marcia Gelber,
Marie F Morin,
Matthew G Brown,
Melanie M Walker,
Michele L Forster, PhD,
Michelle D Haamid,
Michelle Yclark Stuart,
Monica Cburgos Garcia,
Myla D Chapman,
Myoshi M Francis,
Nicole A Lloyd,
Omotunde O Osunsanmi,
Paul W Moy,
Penny H Mccarver,
Perry H Gambrell,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
R Edwadebey Deberry,
Rachael L Cook,
Randy L Clarida,
Reba A Gates,
Rebecca Rodriguez,
Rhonda Alexander,
Richard L Garcia,
Robert C Coleman,
Robert D Tollefsen,
Robert L Lewis, Jr,
Robert P Neligan,
Robert W Turner,
Rose Ashley,
Saundrea A Munroe,
Scott T Ballard,
Seneca D Toms,
Shafiq S Ahadi,
Sharna D Pratt,
Shayla G Turnipseed,
Sheri S Oliver,
Shirley Brown,
Shirley S Brown,
Simone M Edmonson,
Sonya M Edmonds,
Steven J Rush,
Steven M Weinman,
Susan O Oladeji,
Susan T Hadman,
Tajah L Blackburn,
Tamara M Casselman,
Tamika D Cathey,
Tammara A Stephens,
Theresa L Stewart,
Thomas R Withers,
Tomika L Bivens,
Tracy R Ball,
Trang N Cox,
Trang P Nguyen,
Vanessa E Coulter,
Veronica Fuentes, MS,
Vicky C Stoakes,
Viviana Matta,
William P Tonkins,
Yiyue Zhang (nmi), PhD,
Young Kim,
Yun Wu, PhD,
Zhong Li, PhD
Gabriel R Mclemore's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| April, 2009 | EIR | Hospira, Inc. - EIR, 2009-04-29 |
| August, 2009 | FDA 483 | River's Edge Pharmaceuticals, LLC - Form 483, 2009-08-12 |
| January, 2010 | FDA 483 | Dixon Investments Inc - Form 483, 2010-01-25 |
| March, 2010 | FDA 483 | Chiesi USA, Inc. - Form 483, 2010-03-24 |
| April, 2011 | EIR | Covidien LP - EIR, 2011-04-21 |
| August, 2009 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2009-08-19 |
| August, 2010 | FDA 483 | Liebel-Flarsheim Company LLC - Form 483, 2010-08-20 |
| August, 2011 | EIR | Pfizer Inc - EIR, 2011-08-25 |
| August, 2009 | FDA 483 Response | River's Edge Pharmaceuticals, LLC - Form 483R, 2010-01-20 |
| May, 2010 | FDA 483 | P & L Development, LLC - Form 483, 2010-05-13 |
| April, 2009 | FDA 483 | STAT RX USA LLC - Form 483, 2009-04-29 |
| October, 2010 | FDA 483 | ISE Newberry Inc. - Form 483, 2010-10-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more